Periprocedural Drug Therapy in Carotid Artery Stenting: The Need for More Evidence
Gortler D, Schlösser FJ, Muhs BE, Nelson MA, Dardik† A. Periprocedural Drug Therapy in Carotid Artery Stenting: The Need for More Evidence. Vascular 2008, 16: 303-309. PMID: 19344586, DOI: 10.2310/6670.2008.00081.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAnticoagulantsAspirinAtropineCarotid ArteriesCarotid StenosisClopidogrelHeparinHumansHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation InhibitorsPremedicationStentsTiclopidineWarfarinConceptsCarotid endarterectomyLarge prospective cohort studyDual antiplatelet therapyProspective cohort studyCarotid artery stentingCohort studyArtery stentingPeriprocedural settingDrug therapyPharmacologic agentsCarotid arteryHigh riskPatient careTherapyOptimal outcomesRegimenGood validityPatientsMore evidenceOutcomesOptimal timeClopidogrelEndarterectomyMedicationsStenting